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induced decrease in DRA mRNA (50%, P < 0.05) and
protein (40%, P < 0.05) was also markedly alleviated
by ATRA. Further, ATRA significantly blocked the
inhibitory effects of IFN-c on DRA promoter activity.
To evaluate if ATRA exerted these effects through mod-
ulation of IFN-c induced signaling cascade, signal trans-
ducer and activator of transcription factor-1 (STAT-1)
phosphorylation levels were analyzed. IFN-c treatment
induced the activation of STAT-1, however, ATRA co-
treatment significantly diminished IFN-c induced STAT-
1 phosphorylation. In DSS- colitis, mouse model, ATRA
treatment attenuated the reduced expression of DRA
mRNA and protein levels in distal colon of DSS-mice.
Further, the enhanced expression of inflammatory cyto-
kines IL-1b (~10 fold) and CXCl1 (~18 fold) induced by
DSS was also alleviated by ATRA treatment.
Conclusions: These data indicate that ATRA
increases DRA function and expression under inflam-
matory conditions and this could serve as a novel
therapeutic approach in IBD associated diarrhea.
(Work also presented at Digestive Disease Week, May
2014, in Chicago, IL, USA)
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Background: Toll-like Receptor 9 (TLR9) is
expressed mainly in the endosomal membrane of
intestinal cells and mediates intestinal host-microbiota
interaction. Serotonin (5-HT) is an intestinal neuro-
modulator involved in the intestinal immunity and
homeostasis. In addition, a high level of 5-HT has
been described in intestinal inflammation. 5-HT intes-
tinal availability is mainly regulated by the serotonin
transporter (SERT) expressed in enterocytes.
Aim: The interaction of TLR9 with serotoninergic
system remains known. Therefore, the aim of the pres-
ent study was to assess the effects of TLR9 activation
on SERT activity and expression.
Methods: Caco-2 cells and colon from wild type
(WT) and TLR9/ C57BL/10 mice were used in this
study. SERT activity (5-HT uptake) in Caco-2 cells
and SERT expression (RT-qPCR and western blotting)
in both Caco-2 cells and colon from WT and TLR9/
mice, were analyzed. TLR9 mRNA and protein levels
were also measured in Caco-2 cells.
Results: TLR9 activation in Caco-2 cells reduced
SERT activity in a MyD88 independent-way. SERT
mRNA and protein level in both cell lysate and brush
border membrane, were also diminished. SERT pro-
tein expression in colon of TLR9/ mice resulted
augmented compared with WT mice. Interestingly,
activation of TLR9 in Caco-2 cells diminished TLR9
mRNA and protein in the cell lysate; however, TLR9
protein in brush border resulted increased.
Conclusions: The results of this work highlight the
role of TLR9 as a mediator intestinal homeostasis
and/or intestinal inflammation by regulating intestinal
serotoninergic system.
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Background: Multiple sclerosis (MS) is an immune-
mediated demyelinating and neurodegenerative dis-
ease of the central nervous system with a disrupted
blood-brain barrier. Since there is an association
between MS and inflammatory bowel disease, and a
critical role of the gut microbiota in the latter entity
has recently been suggested, we wanted to test the
hypothesis that the intestinal barrier is also targeted
in MS.
Aim: We aimed to investigate whether intestinal
permeability is affected during the progression of
Experimental autoimmune encephalomyelitis (EAE), a
well-known animal model of MS, and to examine if
there is a disruption of mucosal immune homeostasis.
Methods: EAE was induced in C57BL/6 mice either
by active immunization or adoptive transfer of autore-
active T-cells. The intestinal permeability was assessed
in vivo to a small molecule (sodium fluorescein) and a
macromolecular protein (FITC-BSA) marker, prior to
the onset and at the stage of paralysis. The intestinal
samples were analyzed for histological changes, tight
junction regulator protein (zonulin), and inflammatory
parameters.
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